October 24, 2014 3:11 PM ET


Company Overview of Harkness Pharmaceuticals, Inc.

Company Overview

Harkness Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel therapies for obesity. It offers enterostatin, a pentapeptide endogenous to humans and other mammals. The company was founded in 2003 and is based in San Diego, California with an additional office in Rochester, New York.

4401 Eastgate Mall

San Diego, CA 92121

United States

Founded in 2003





Key Executives for Harkness Pharmaceuticals, Inc.

Chairman and Chief Executive Officer
Age: 70
Founder and Director
Age: 72
Director of Business Development and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Mammouth Inc. United States
Alphagene Inc. United States
Adnexus Therapeutics, Inc. United States
Parasitix Corporation United States
Imbed Biosciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Harkness Pharmaceuticals, Inc., please visit www.harknesspharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.